Apoptosis of Human Gallbladder Carcinoma GBC-SD Cells Induced by Withaferin A and Its Possible Mechanism

Xu Li,Min Wang,Rui Tian,Zheng He,Feng Peng,Xiaomao Guo,Renyi Qin
2013-01-01
Tumori
Abstract:Objective: To investigate WA (withaferin A)-induced apoptosis of human gallbladder carcinoma GBC-SD cells in vitro and to explore its possible mechanism. Methods: The proliferation of GBC-SD cells after treatment with different concentrations of WA was detected by CCK-8 (cell counting kit-8) assay. The apoptotic morphology and super-microstructural changes were observed by using Hoechst 33258 fluorescent staining and under a transmission electron microscope. The apoptosis rate and the cell cycle distribution of GBC-SD cells were detected by flow cytometry. The expressions of PARP [poly (ADP-ribose) polymerase], cyclin D1, cyclin B1, Cdk1 (cyclin-dependent kinase 1) and p21 in GBC-SD cells were detected by Western blotting. Results: WA could significantly inhibit the proliferation of GBC-SD cells in a dose- and time-dependent manner (P < 0.05). WA could also induce typical apoptotic morphological and super-microstructural changes of GBC-SD cells. As compared with the GBC-SD cells without WA treatment, WA could significantly increase the percentage of apoptotic GBC-SD cells (P < 0.01) and caused the cell arrest at G2/M phase. WA could also significantly down-regulate the expression levels of cyclin D1 and Cdk1 proteins (P < 0.05), whereas up-regulate the expression levels of cyclin B1 and p21 proteins (P < 0.05) and promote the cleavage of PARP (P < 0.05). Conclusion: WA could induce the GBC-SD cell arrest at G2/M phase by down-regulating the expression levels of cyclin D1 and Cdk1 and up-regulating the expression levels of cyclin B1 and p21. These effects may lead to the suppression of cellular proliferation and the apoptosis of GBC-SD cells. DOI:10.3781/j.issn.1000-7431.2013.06.004
What problem does this paper attempt to address?